Free Trial

Immunome (IMNM) SEC Filings & 10K Form

Immunome logo
$9.90 -0.05 (-0.50%)
Closing price 08/28/2025 04:00 PM Eastern
Extended Trading
$10.04 +0.14 (+1.45%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Immunome SEC Filings

DateFilerForm TypeView
07/31/2025
5:51 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2025
5:52 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2025
5:55 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2025
5:57 PM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2025
5:59 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2025
6:00 PM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2025
5:48 PM
Immunome (Issuer)
Stoneman Sandra G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:50 PM
Immunome (Issuer)
SWAIN SANDRA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:52 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:54 PM
Barchas Isaac (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:55 PM
Immunome (Issuer)
WAGENHEIM PHILIP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
3:58 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
8:21 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
8:01 PM
Immunome (Subject)
Redmile Group, LLC (Filed by)
Form SCHEDULE 13G/A
05/15/2025
1:04 PM
EcoR1 Capital, LLC (Filed by)
Immunome (Subject)
Form SCHEDULE 13G/A
05/14/2025
9:40 AM
Immunome (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
03/28/2025
4:54 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
4:15 PM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
4:18 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:10 PM
Immunome (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/19/2025
3:11 PM
Immunome (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
11:35 AM
Immunome (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/04/2025
4:44 PM
Immunome Aggregator, LP (Filed by)
Immunome (Subject)
Form SCHEDULE 13D/A
02/03/2025
8:01 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:08 PM
Immunome (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
01/30/2025
8:57 PM
Immunome (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/30/2025
3:24 PM
Immunome (Filer)
Form 424B5
01/30/2025
3:28 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
3:29 PM
Immunome (Filer)
Form 424B5
01/23/2025
3:01 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2024
7:35 AM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
7:41 AM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
7:33 AM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:00 PM
Immunome (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/14/2024
9:33 AM
Immunome (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G
11/13/2024
3:06 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
2:57 PM
Immunome (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:54 AM
Immunome (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/29/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Immunome (Subject)
Form SC 13G
10/08/2024
3:31 PM
Immunome (Filer)
Form S-3ASR
Market Panic: Trump Just Dropped a Bomb on Your Stocks (Ad)

tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.tc pixel

Don't wait for the next drop to wipe you out. Get the FREE Guide Before Markets Open Tomorrow
10/07/2024
6:14 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
6:26 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
1:18 PM
Immunome (Subject)
Rosett Max (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IMNM) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners